Lv41
436 积分 2023-04-27 加入
IgA Nephropathy in Adults
2小时前
待确认
Evaluating Sibeprenlimab in IgA Nephropathy - Rationale and Baseline Data from the VISIONARY Trial
5小时前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
5小时前
已完结
Sibeprenlimab, which neutralizes A PRoliferation Inducing Ligand (APRIL), as a new approach to treating IgA nephropathy
6小时前
已完结
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers
6小时前
已完结
Narsoplimab: First Approval
8小时前
已完结
Sibeprenlimab: First Approval
8小时前
已完结
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
2天前
已完结
Therapeutic strategies for hepatitis B virus infection: towards a cure
2天前
已完结
Assessment of toxicity and tolerability of a combination vehicle; 5% Pharmasolve, 45% Propylene glycol and 50% Polyethylene glycol 400 in rats following repeated intravenous administration
2天前
已完结
皖公网安备34019202002308
